SCHEMBL1629392

SCHEMBL1629392

B[PH](CCC(=O)OC)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 1/20 0.44
AKT1 P31749 1/20 0.43
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
POLB P06746 2/20 0.41
CA12 O43570 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
ESRRB O95718 1/20 0.41
TSHR P16473 3/20 0.41
MEN1 O00255 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9524467 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EAKT1MAPT
SCHEMBL17361242 0.76 ALDH1A1 (0.51) ALDH1A1LMNAKDM4EAKT1MAPT
Bromide SCHEMBL28529432 0.75 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EAKT1MAPT
SCHEMBL17385252 0.75 ALDH1A1 (0.50) ALDH1A1LMNAKDM4EAKT1MAPT
SCHEMBL27065040 0.73 LMNA (0.49) ALDH1A1LMNAKDM4EMAPTKMT2A
SCHEMBL13285868 0.73 LMNA (0.49) ALDH1A1LMNAKDM4EMAPTKMT2A
SCHEMBL15132436 0.73 LMNA (0.49) ALDH1A1LMNAKDM4EMAPTKMT2A
Bromide SCHEMBL5074991 0.72 LMNA (0.48) ALDH1A1LMNAKDM4EMAPTKMT2A
Bromide SCHEMBL5075234 0.72 LMNA (0.48) ALDH1A1LMNAKDM4EMAPTKMT2A
Phthalic Acid SCHEMBL28233805 0.72 ALDH1A1 (0.58) ALDH1A1LMNAKDM4EAKT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398477-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH Wisconsin Alumni Research Foundation (US) 2011-12-28 EP claimed
US-7932239-B2 Methods of and compositions for reducing neuronal cell death WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-04-26 US claimed
US-20100256093-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH WISCONSIN ALUMNI RESEARCH FOUNDATION 2010-10-07 US claimed
WO-2010096778-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-08-26 WO claimed
US-20060258622-A1 Methods of and compositions for reducing neuronal cell death NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-11-16 US claimed
US-8415327-B2 Methods of and compositions for reducing cell death WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-09 US disclosed
EP-2398477-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH Wisconsin Alumni Research Foundation (US) 2011-12-28 EP disclosed
US-20110195931-A1 METHODS AND COMPOSITIONS FOR REDUCING NEURONAL CELL DEATH WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-08-11 US disclosed
US-7932239-B2 Methods of and compositions for reducing neuronal cell death WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2011-04-26 US disclosed
US-20100256093-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH WISCONSIN ALUMNI RESEARCH FOUNDATION 2010-10-07 US disclosed
WO-2010096778-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-08-26 WO disclosed
US-20060258622-A1 Methods of and compositions for reducing neuronal cell death NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258622-A1 Methods of and compositions for reducing neuronal cell death CASP3, BAX, CASP9 ALDH1A1 4149/4885LMNA 128/4885KDM4E 2878/4885
US-20110195931-A1 METHODS AND COMPOSITIONS FOR REDUCING NEURONAL CELL DEATH CASP3, BAX, CASP9 ALDH1A1 4172/4885LMNA 115/4885KDM4E 2570/4885
US-20100256093-A1 METHODS OF AND COMPOSITIONS FOR REDUCING CELL DEATH BAX, CASP3, BCL2 ALDH1A1 4139/4885LMNA 76/4885KDM4E 2985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.